that would involve getting pricked with a needle at your local Quest Diagnostics. It sounds a bit antiquated, doesn’t it? These days, you can order a home test for everything from colon cancer ...

That doctor might, or might not, order further testing for you—a blood panel, say, that would involve getting pricked with a needle at your local Quest Diagnostics. It sounds a bit antiquated, doesn’t ...

Quest Diagnostics (NYSE:DGX) announced on Wednesday that it will roll out a rapid molecular lab test to detect the avian ...

Oct 23 - Lab operator Quest Diagnostics (DGX.N), opens new tab said on Wednesday it will launch a test for H5N1 bird flu at ...

Quest Diagnostics reported strong third-quarter earnings driven by acquisitions, with revenue surpassing expectations, though ...

Quest Diagnostics benefits from an aging population, driving increased lab testing volumes, and offers 2.0% dividend yield.

Leerink Partners analyst Michael Cherny has reiterated their neutral stance on DGX stock, giving a Hold rating yesterday. Michael Cherny has ...

Morgan Stanley analyst Erin Wright maintained a Hold rating on Quest Diagnostics (DGX – Research Report) today and set a price target of ...

Laboratory operator Quest Diagnostics beat Wall Street estimates for third-quarter profit and revenue on Tuesday, helped by robust demand for its diagnostic tests. Demand for diagnostic checkups has ...